- Trials with a EudraCT protocol (26)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (17)
26 result(s) found for: Gaviscon.
Displaying page 1 of 2.
EudraCT Number: 2012-000678-44 | Sponsor Protocol Number: GA1116 | Start Date*: 2012-09-04 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
Medical condition: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-006413-25 | Sponsor Protocol Number: GA0821 | Start Date*: 2008-12-09 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
Full Title: A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon ... | ||
Medical condition: Symptoms of heartburn | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002188-84 | Sponsor Protocol Number: GA1203 | Start Date*: 2012-07-27 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) LTD | ||
Full Title: A multi-centred, randomised, double-blind, two arm, parallel group, placebo-controlled, pilot study to assess the effect of Gaviscon Double Action Tablets in patients with reflux disease | ||
Medical condition: This pilot study of Gaviscon Double Action Tablets is to be conducted to demonstrate that Gaviscon Double Action Tablets are effective in managing the symptoms of heartburn, acid regurgitation and ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005821-31 | Sponsor Protocol Number: GA0706 | Start Date*: 2008-01-15 |
Sponsor Name:Reckitt Benckiser Healthcare UK) Limited [...] | ||
Full Title: A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liq... | ||
Medical condition: Symptoms of heartburn | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019072-68 | Sponsor Protocol Number: version 1 (07/10/2010) | Start Date*: 2010-12-31 |
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | ||
Full Title: A randomised, double blind, crossover study to determine the mechanism of action of Gaviscon Advance in Gastro-Oesophageal Reflux Disease (GORD) | ||
Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002341-35 | Sponsor Protocol Number: GA1103 | Start Date*: 2011-07-21 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A randomised single dose two cohort study comparing the speed of raft formation assessed by gamma scintigraphy in healthy volunteers following administration of a single dose of Gaviscon® Strawberr... | ||
Medical condition: To measure the formation and retention of alginate rafts in healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004725-27 | Sponsor Protocol Number: GA1109 | Start Date*: 2012-01-24 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single-centre, randomised, double-blind, two-way crossover, placebo-controlled pilot study, investigating the use of a novel intragastric and oesophageal pH catheter to characterise the antacid a... | ||
Medical condition: To pilot the use of a novel pH catheter for the measurement of oesophageal and intragastric pH comparing the onset and duration of antacid action of Gaviscon Double Action versus placebo. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021630-63 | Sponsor Protocol Number: GA1001 | Start Date*: 2011-03-28 |
Sponsor Name:Reckitt Benckiser | ||
Full Title: A randomised, double blind placebo controlled study in patients with reflux symptoms to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Peppermint liquid’ using the BRAVO... | ||
Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-004131-23 | Sponsor Protocol Number: GA1212 | Start Date*: 2013-01-18 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single-centre, randomised, 2 way crossover, double blind, placebo controlled study in healthy volunteers, to characterise the antacid activity of Gaviscon Double Action Mint Liquid in the fasted ... | ||
Medical condition: This study is to demonstrate the antacid action of Gaviscon Double Action Mint versus a matched placebo using a pH catheter. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-000539-42 | Sponsor Protocol Number: RB2-NL-1518 | Start Date*: 2016-04-15 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
Full Title: A randomised, single dose, crossover, open label, placebo controlled confirmatory study in healthy volunteers to characterise the acid neutralisation activity of Gaviscon Double Action Liquid in th... | ||
Medical condition: To investigate the pH of the acid in the stomach of healthy volunteers after the intakeof Gaviscon Double Action liquid. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003158-15 | Sponsor Protocol Number: GA1406 | Start Date*: 2014-10-10 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
Full Title: A randomised, assessor blind, placebo controlled exploratory study in healthy volunteers, to characterise the acid neutralisation activity of sodium alginate oral suspension in the fasted state, us... | ||
Medical condition: To pilot the use of a custom designed pH catheter for the measurement of intragastric pH to characterise the antacid action of Gaviscon Double Action versus placebo. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004109-28 | Sponsor Protocol Number: GA1211 | Start Date*: 2013-01-18 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A randomised, 4 way crossover, double blind, placebo controlled pilot study in patients with reflux symptoms, to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Mint ’ us... | ||
Medical condition: This study assesses suppression of gastro-oesophageal reflux of Gaviscon in patients with gastro-oesophageal reflux disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-004470-25 | Sponsor Protocol Number: GA1214 | Start Date*: 2013-01-08 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A multicentre, randomised, double-blind, two arm, parallel group, pilot study to assess the effect of Gaviscon® Double Action Mint as add-on therapy in GORD patients with inadequate response to onc... | ||
Medical condition: Patients with Gastro Oesophageal Reflux Disease (GORD) with inadequate response to PPI treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005486-21 | Sponsor Protocol Number: GA1102 | Start Date*: 2012-01-26 | |||||||||||
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd. | |||||||||||||
Full Title: A multicentre, randomised, double-blind, two arm, parallel group, placebo controlled, pilot study to assess the effect of Gaviscon Advance as add-on therapy in GORD patients with inadequate respons... | |||||||||||||
Medical condition: Gastro Oesophageal Reflux Disease (GORD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001526-13 | Sponsor Protocol Number: 23/2008/O/Sper | Start Date*: 2008-06-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Efficacy of Gaviscon in the treatment of gastroesophageal reflux in preterm newborns | |||||||||||||
Medical condition: gastroesophageal reflux in preterm newborns | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004062-17 | Sponsor Protocol Number: NEK/MD/0119 | Start Date*: 2020-12-03 |
Sponsor Name:Nekkar Lab srl | ||
Full Title: OPEN, COMPARATIVE STUDY TO EVALUATE THE PERFORMANCE AND SAFETY OF THE MEDICAL DEVICE MARIAL® IN ASSOCIATION WITH PROTON-PUMP INHIBITORS VERSUS PPI ALONE IN PATIENTS AFFECTED BY GASTROESOPHAGEAL REF... | ||
Medical condition: gastroesophageal reflux disease (GERD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004561-41 | Sponsor Protocol Number: FGC-19-003 | Start Date*: 2020-03-20 | |||||||||||
Sponsor Name:The Functional Gut Clinic | |||||||||||||
Full Title: The use of Antacids and Alginates during Pre-Investigation Proton Pump Inhibitor Washout: Impact on Compliance and Symptom Burden | |||||||||||||
Medical condition: Gastro-oesophageal reflux disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019414-24 | Sponsor Protocol Number: GA0921 | Start Date*: 2010-07-09 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets... | ||
Medical condition: Investigating efficacy in terms of heatburn relief in healthy subjects following a refluxogenic meal. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003716-91 | Sponsor Protocol Number: CGB-1108 | Start Date*: 2023-02-21 | |||||||||||
Sponsor Name:Centrum Gastroenterologie Bethanien | |||||||||||||
Full Title: Randomized controlled clinical trial to evaluate the efficacy of alginates in washout of proton pump inhibitor therapy with consideration of compliance and symptom burden in patients with gastroeso... | |||||||||||||
Medical condition: Randomized controlled clinical trial to evaluate the efficacy of alginates in washout of proton pump inhibitor therapy with consideration of compliance and symptom burden in patients with gastroeso... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019563-11 | Sponsor Protocol Number: RB10001 | Start Date*: 2010-06-01 | ||||||||||||||||||||||||||
Sponsor Name:RECKITT BENCKISER HEALTHCARE | ||||||||||||||||||||||||||||
Full Title: Etude de non-infériorité de l’efficacité de Gaviscon suspension buvable en flacon versus Oméprazole 20mg sur le pyrosis chez des patients ayant un RGO dont l’épisode actuel n’est pas traité. | ||||||||||||||||||||||||||||
Medical condition: Patient volontaire présentant un épisode de RGO non traité et venant consulter en médecine générale. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.